Efficacy and Mechanisms of Midazolam in Inhibiting Cancer Progression Dr Monish Raut17 Dec 2023 11:30 PM ISTResearchers have found in a new study that midazolam has the potential to impede cancer progression and decrease cancer cell survival. The new...
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
GSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for endometrial cancer Ruchika Sharma13 Dec 2023 3:30 PM ISTLondon: GSK plc has announced the European Commission (EC) has granted marketing authorisation for Jemperli (dostarlimab) in combination with...
AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Docetaxel use associated with significant reduction in prostate cancer death Isra Zaman4 Nov 2023 9:15 AM ISTIn a new study, investigators from Brigham and Women's Hospital, a meta-analysis of five prospective randomized clinical trials (RCTs) found that...
Bristol Myers Squibb Opdivo in combo with cisplatin based chemotherapy gets EMA validation for Urothelial Carcinoma Ruchika Sharma31 Oct 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its type II variation application for...
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Surgery, Radiotherapy, Chemotherapy- What treatment to undergo?- Ft. Dr. Monique Gary, Breast Surgeon Dr. Monique Gary21 Oct 2023 1:51 PM ISTAlthough cancer can develop at any life stage, studies show that it is more common in old people. In a report on its website, the National Library of...
GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer Ruchika Sharma19 Oct 2023 2:41 PM ISTUK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
European Commission nod to Merck Keytruda for non-small cell lung cancer at high risk of recurrence Ruchika Sharma17 Oct 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
AstraZeneca gets USFDA priority review for Tagrisso plus chemotherapy for EGFR-mutated advanced lung cancer Ruchika Sharma17 Oct 2023 2:24 PM ISTCambridge: AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and...
Merck gets USFDA nod for neoadjuvant/ adjuvant Keytruda for resectable non-small cell lung cancer Ruchika Sharma17 Oct 2023 12:54 PM ISTThe approval marks the sixth NSCLC indication for KEYTRUDA.
